Now you know...

PTEI was incorporated in 1996 as the Pittsburgh Tissue Engineering Initiative. Today, the name PTEI is internationally recognized and synonymous for high-quality programming.

 

When the Pittsburgh Tissue Engineering Initiative, Inc. (PTEI)
was established in 1996, its mission was to support the growth
of a regional industry through focused efforts to facilitate
commercialization of university-derived technologies associated
with engineered tissues.

---

This mission reflected PTEI’s early efforts to establish Pittsburgh as a major hub of U.S. research and technology development in tissue engineering, a field of biomedicine that was in its infancy — full of promise, but unproven.

In the intervening years PTEI experienced remarkable success — and remarkable changes in programs and scope, moving from a region-centric, economic-driven mission to one that is patient-centered and international in scale.

Lessons gleaned in coordinating activities among regional academic partners are now applied to directing national research programs for the U.S. Department of Defense, supporting professional training for scientists, creating award-winning science education programs for “students” of all ages, and bridging geographic and scientific boundaries to link scientists and industry partners around the world.

These innovative programs in research, education and industry network development enhance the very means by which regenerative therapies are developed, and will accelerate their delivery to patients.

Today, PTEI is a recognized international leader in the field.

We’ve expanded our focus to include the full range of regenerative therapies — from tissue engineering, gene and cellular therapies, and bio-artificial organ development, to the spectrum of enabling technologies making research possible. And we’ll continue to evolve to meet the changing needs of those we serve, advancing regenerative medicine, step by step.